Diversified Healthcare Trust (NASDAQ:DHC) Price Target Raised to $5.50

Diversified Healthcare Trust (NASDAQ:DHC) had its price objective raised by B. Riley from $4.50 to $5.50 in a research note published on Wednesday,Benzinga reports. B. Riley currently has a buy rating on the real estate investment trust’s stock. B. Riley also issued estimates for Diversified Healthcare Trust’s Q4 2025 earnings at $0.04 EPS, FY2025 earnings at $0.26 EPS, Q1 2026 earnings at $0.14 EPS, Q2 2026 earnings at $0.15 EPS, Q3 2026 earnings at $0.15 EPS and FY2026 earnings at $0.58 EPS.

Diversified Healthcare Trust Price Performance

DHC stock opened at $4.58 on Wednesday. The firm has a 50 day moving average price of $3.74 and a 200-day moving average price of $3.18. Diversified Healthcare Trust has a 52-week low of $2.00 and a 52-week high of $4.61. The firm has a market capitalization of $1.11 billion, a price-to-earnings ratio of -3.85 and a beta of 2.62. The company has a debt-to-equity ratio of 1.42, a quick ratio of 6.35 and a current ratio of 6.35.

Diversified Healthcare Trust (NASDAQ:DHC) last released its earnings results on Monday, August 4th. The real estate investment trust reported $0.08 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.08. The firm had revenue of $382.71 million during the quarter, compared to analyst estimates of $382.74 million. Diversified Healthcare Trust had a negative net margin of 18.83% and a negative return on equity of 14.69%.

Diversified Healthcare Trust Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, August 14th. Stockholders of record on Monday, July 21st were paid a dividend of $0.01 per share. This represents a $0.04 annualized dividend and a dividend yield of 0.9%. The ex-dividend date was Monday, July 21st. Diversified Healthcare Trust’s dividend payout ratio (DPR) is currently -3.36%.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the company. Cim Investment Management Inc. lifted its stake in shares of Diversified Healthcare Trust by 100.7% during the 2nd quarter. Cim Investment Management Inc. now owns 112,707 shares of the real estate investment trust’s stock valued at $403,000 after buying an additional 56,556 shares in the last quarter. State of Wyoming purchased a new position in shares of Diversified Healthcare Trust during the 2nd quarter valued at $178,000. Carronade Capital Management LP lifted its stake in shares of Diversified Healthcare Trust by 588.7% during the 2nd quarter. Carronade Capital Management LP now owns 1,618,448 shares of the real estate investment trust’s stock valued at $5,794,000 after buying an additional 1,383,448 shares in the last quarter. CANADA LIFE ASSURANCE Co lifted its stake in shares of Diversified Healthcare Trust by 10.8% during the 2nd quarter. CANADA LIFE ASSURANCE Co now owns 304,316 shares of the real estate investment trust’s stock valued at $1,087,000 after buying an additional 29,571 shares in the last quarter. Finally, Tower Research Capital LLC TRC lifted its stake in shares of Diversified Healthcare Trust by 222.2% during the 2nd quarter. Tower Research Capital LLC TRC now owns 24,008 shares of the real estate investment trust’s stock valued at $86,000 after buying an additional 16,556 shares in the last quarter. Hedge funds and other institutional investors own 75.98% of the company’s stock.

Diversified Healthcare Trust Company Profile

Diversified Healthcare Trust is a real estate investment trust, which engages in the ownership of senior living communities, medical office buildings, and wellness centers. It operates through the following segments: Office Portfolio, Senior Housing Operating Portfolio (SHOP), and Non-Segment. The Office Portfolio segment consists of medical office properties leased to medical providers and other medical related businesses, as well as life science properties leased to biotech laboratories and other similar tenants.